Litigation Details for TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)

TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)

Docket		Date Filed	2020-04-28
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Kevin McNulty
Jury Demand		Referred To	Edward S. Kiel
Patents	6,419,960; 9,545,399; 9,844,544
Link to Docket	External link to docket

Details for TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
2022-08-16	206	Opinion	of five patents: United States Patent No. 9,545,399 (“the ’399 patent”), United States Patent No. 9,844,544…the ’544 patent”), United States Patent No. 9,844,545 (“the ’545 patent”), United States Patent No. 11,103,494…,494 (“the ’494 patent”), and United States Patent No. 11,103,495 (“the ’495 patent”) (collectively,…the ’399 patent; claim 37 of the ’544 patent; claims 17, 23, 24, and 28 of the ’545 patent; claim 28…the ’399 patent, claim 37 of the ’544 patent, claims 17, 23, 24, and 28 of the ’545 patent, and claim	External link to document
2022-09-06	223	Opinion	• U.S. Patent No. 4,996,047 (“Kelleher”) (JTX-059) • U.S. Patent No. 6,419,960 (“Krishnamurthy…of five patents: United States Patent No. 9,545,399 (“the ’399 patent”), United States Patent No. 9,844,544…the ’544 patent”), United States Patent No. 9,844,545 (“the ’545 patent”), United States Patent No. 11,103,494…,494 (“the ’494 patent”), and United States Patent No. 11,103,495 (“the ’495 patent”) (collectively,…the ’399 patent; claim 37 of the ’544 patent; claims 17, 23, 24, and 28 of the ’545 patent; claim 28	External link to document